摘要
2019年8月巴黎欧洲心脏病学会(ESC)年会上公布了慢性冠状动脉综合征(CCS)指南,该指南刷新了2013年发布的《稳定性冠状动脉疾病治疗指南》,提出了慢性冠状动脉综合征的概念。新指南的颁布抛弃了“稳定”这一概念,提出了冠心病全程管理的理念,强调了CTCA在非侵入诊断中的价值,提出了对高缺血风险患者长期双联抗栓的重要性,提升了NOAC以及新型调脂与降糖药物的地位。
ESC announced the guidelines of chronic coronary artery syndrome (CCS) at the annual conference in August, 2019. The guidelines changed《Guidelines for Stable Coronary Artery Diseases》issued 2013 and raised the concept of CCS. The new guidelines abandoned the concept of "stable" and put forward the idea of whole course management for coronary artery disease. It stressed the value of CT coronary arteriography in the noninvasive examinations. It pointed out the importance of long-term dual antithrombotic therapy for the high ischemia risk patients. It emphasized the significance of the new type oral anticoagulants and the new type medications regulating the blood lipid and sugar.
作者
杨新春
张大鹏
YANG Xin-chun;ZHANG Da-peng(Heart Center,Beijing Chaoyang Hospital,Capital Medcial University,Beijing 100020,China)
出处
《中国心血管病研究》
CAS
2019年第10期871-873,共3页
Chinese Journal of Cardiovascular Research
关键词
慢性冠状动脉综合征
冠状动脉疾病
CT冠状动脉成像
双联抗栓
新型口服抗凝药物
Chronic coronary artery syndrome
Coronary artery diseases
CT coronary arteriography
Dual antithrombotic therapy
New type oral anticoagulants
